Research Article
Design, Characterization, and Optimization of Controlled Drug Delivery System Containing Antibiotic Drug/s
Table 5
Formulation of osmotic tablet (F13–F20).
| Ingredient | Batch number | F13 | F14 | F15 | F16 | F17 | F18 | F19 | F20 |
| Dicloxacillin sodium (mg) | 244 | 244 | 244 | 244 | 244 | 244 | 244 | 244 | NaCl (mg) | 100 | 100 | 50 | 100 | 150 | 50 | 50 | 100 | SLS (mg) | 10 | 10 | 20 | 20 | 20 | 15 | 15 | 20 | PVP K30 (mg) | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | CA (%) | 4 | 2 | 3 | 4 | 3 | 4 | 2 | 2 | PEG 400 (%) | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | Magnesium stearate (mg) | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | Talc (mg) | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | Coloring agent | q.s | q.s | q.s | q.s | q.s | q.s | q.s | q.s |
|
|